These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 907238)

  • 1. Pathophysiology of spironolactone-induced gynecomastia.
    Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH
    Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecomastia induced in normal males by spironolactone.
    Huffman DH; Kampmann JP; Hignite CE; Azarnoff DL
    Clin Pharmacol Ther; 1978 Oct; 24(4):465-73. PubMed ID: 688736
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men.
    Miyatake A; Noma K; Nakao K; Morimoto Y; Yamamura Y
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):523-33. PubMed ID: 747893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecomastia and semen abnormalities induced by spironolactone in normal men.
    Caminos-Torres R; Ma L; Snyder PJ
    J Clin Endocrinol Metab; 1977 Aug; 45(2):255-60. PubMed ID: 885991
    [No Abstract]   [Full Text] [Related]  

  • 6. Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia.
    Pont A; Goldman ES; Sugar AM; Siiteri PK; Stevens DA
    Arch Intern Med; 1985 Aug; 145(8):1429-31. PubMed ID: 4040740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced gynecomastia].
    Schirren U; Hinz B; Schirren C
    Andrologia; 1986; 18(1):104-7. PubMed ID: 3954080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of spironolactone in essential hypertension.
    Jeunemaitre X; Chatellier G; Kreft-Jais C; Charru A; DeVries C; Plouin PF; Corvol P; Menard J
    Am J Cardiol; 1987 Oct; 60(10):820-5. PubMed ID: 3661395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production.
    Satoh T; Itoh S; Seki T; Itoh S; Nomura N; Yoshizawa I
    J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):209-16. PubMed ID: 12477487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecomastia in men following antineoplastic therapy.
    Trump DL; Pavy MD; Staal S
    Arch Intern Med; 1982 Mar; 142(3):511-3. PubMed ID: 6802094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical trial for the comparison of tolerance of two aldosterone antagonists].
    Leizorovicz A; Guenaneche F; Luciani J; Boissel JP
    Therapie; 1991; 46(4):327-31. PubMed ID: 1948810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia.
    Fukuchi K; Sasaki H; Yokoya T; Noguchi T; Goto Y; Hayashida K; Ishida Y
    Clin Nucl Med; 2005 Feb; 30(2):105-6. PubMed ID: 15647677
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic liver cirrhosis.
    Kley HK; Niederau C; Stremmel W; Lax R; Strohmeyer G; Krüskemper HL
    J Clin Endocrinol Metab; 1985 Jul; 61(1):1-6. PubMed ID: 3998072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action].
    Corvol P; Mahoudeau JA; Valcke JC; Ménard J; Bricaire H
    Nouv Presse Med; 1976 Mar; 5(11):691-4. PubMed ID: 177946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of androgens to estrogens in cirrhosis of the liver.
    Gordon GG; Olivo J; Rafil F; Southren AL
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1018-26. PubMed ID: 1133151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal steroid hormone metabolism during administration of various drugs].
    Miyazaki T; Araki Y
    Nihon Rinsho; 1979 Jun; 37(6):1283-8. PubMed ID: 384052
    [No Abstract]   [Full Text] [Related]  

  • 18. Gynecomastia caused by estrogen containing hair lotion.
    Gottswinter JM; Korth-Schütz S; Ziegler R
    J Endocrinol Invest; 1984 Aug; 7(4):383-6. PubMed ID: 6438223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of spironolactone on sex hormones in man.
    Stripp B; Taylor AA; Bartter FC; Gillette JR; Loriaux DL; Easley R; Menard RH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):777-81. PubMed ID: 1176584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.